LINC01002 Targets miR-650/FLNA Pathway to Suppress Prostate Cancer Progression

Conclusion: LINC01002 deregulation was linked to PCa development. LINC01002 exerted potential anticancer effects in PCa via targeting the miR-650/FLNA pathway, which, at least in part, provided a basis for the involvement of LINC01002 as a therapeutic target in PCa.Urol Int
Source: Urologia Internationalis - Category: Urology & Nephrology Source Type: research